|
#
|
Concept name
|
Type
|
Relation
|
Support
|
Score
|
|
1
|
Anisometropia
|
Disease
|
Known
|
Explain
|
0.59251
|
|
2
|
inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity
|
Function
|
Known
|
Explain
|
0.58659
|
|
3
|
Language Delay
|
Disease
|
Known
|
Explain
|
0.56535
|
|
4
|
phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
|
Function
|
Known
|
Explain
|
0.54003
|
|
5
|
Bannayan-Riley-Ruvalcaba Syndrome
|
Other
|
Known
|
Explain
|
0.49336
|
|
6
|
phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity
|
Function
|
Known
|
Explain
|
0.41803
|
|
7
|
phosphatidylethanolamine
|
Compound
|
Known
|
Explain
|
0.37985
|
|
8
|
inositol-1,3,-bisphosphate 3-phosphatase activity
|
Function
|
Known
|
Explain
|
0.36404
|
|
9
|
Bifunctional phosphatidylinositol trisphosphate phosphatase/dual-specificity phosphatase PTEN
|
Domain
|
Known
|
Explain
|
0.35431
|
|
10
|
Cutaneous Melanoma
|
Disease
|
Known
|
Explain
|
0.31812
|
|
11
|
Lipoma
|
Disease
|
Known
|
Explain
|
0.31553
|
|
12
|
Developmental Coordination Disorder
|
Disease
|
Known
|
Explain
|
0.29025
|
|
13
|
MENINGIOMA, FAMILIAL
|
Disease
|
Known
|
Explain
|
0.27966
|
|
14
|
regulation of B cell apoptosis
|
Function
|
Known
|
Explain
|
0.25660
|
|
15
|
Lipomatosis
|
Disease
|
Known
|
Explain
|
0.25508
|
|
16
|
Phosphatidylserines
|
Compound
|
Known
|
Explain
|
0.24132
|
|
17
|
miRBase:hsa-mir-217
|
MicroRNA
|
Known
|
Explain
|
0.23861
|
|
18
|
Phosphatidylinositol-3,4,5-trisphosphate
|
Compound
|
Known
|
Explain
|
0.23079
|
|
19
|
phosphoinositide dephosphorylation
|
Function
|
Known
|
Explain
|
0.21409
|
|
20
|
VACTERL ASSOCIATION WITH HYDROCEPHALUS
|
Disease
|
Known
|
Explain
|
0.21088
|
|
21
|
inositol phosphate dephosphorylation
|
Function
|
Known
|
Explain
|
0.20438
|
|
22
|
Phosphatase tensin type
|
Domain
|
Known
|
Explain
|
0.20040
|
|
23
|
negative regulation of phagocytosis
|
Function
|
Known
|
Explain
|
0.19425
|
|
24
|
Endometrial Hyperplasia
|
Disease
|
Known
|
Explain
|
0.19418
|
|
25
|
Tensin phosphatase, C2 domain
|
Domain
|
Known
|
Explain
|
0.18852
|
|
26
|
regulation of myeloid cell apoptosis
|
Function
|
Known
|
Explain
|
0.18296
|
|
27
|
negative regulation of focal adhesion formation
|
Function
|
Known
|
Explain
|
0.16411
|
|
28
|
LEOPARD Syndrome
|
Disease
|
Known
|
Explain
|
0.16033
|
|
29
|
Proteus Syndrome
|
Disease
|
Known
|
Explain
|
0.15270
|
|
30
|
Follicular thyroid carcinoma
|
Disease
|
Known
|
Explain
|
0.14925
|
|
31
|
Hamartoma Syndrome, Multiple
|
Disease
|
Known
|
Explain
|
0.14799
|
|
32
|
1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate
|
Compound
|
Known
|
Explain
|
0.14674
|
|
33
|
Hemangioma
|
Disease
|
Known
|
Explain
|
0.13276
|
|
34
|
negative regulation of protein kinase B signaling cascade
|
Function
|
Known
|
Explain
|
0.13256
|
|
35
|
Phosphatidylcholines
|
Compound
|
Known
|
Explain
|
0.11626
|
|
36
|
lipid phosphatase activity
|
Function
|
Inferred
|
Explain
|
0.11215
|
|
37
|
Hypertrophy
|
Disease
|
Known
|
Explain
|
0.10969
|
|
38
|
response to arsenic
|
Function
|
Known
|
Explain
|
0.10376
|
|
39
|
cardiac muscle development
|
Function
|
Known
|
Explain
|
0.10073
|
|
40
|
platelet-derived growth factor receptor binding
|
Function
|
Known
|
Explain
|
0.09870
|
|
41
|
Dual specificity phosphatase, catalytic domain
|
Domain
|
Known
|
Explain
|
0.09801
|
|
42
|
miRBase:hsa-mir-19a
|
MicroRNA
|
Known
|
Explain
|
0.09273
|
|
43
|
regulation of protein stability
|
Function
|
Known
|
Explain
|
0.08203
|
|
44
|
endothelial cell migration
|
Function
|
Known
|
Explain
|
0.08112
|
|
45
|
response to ATP
|
Function
|
Known
|
Explain
|
0.07782
|
|
46
|
platelet-derived growth factor receptor signaling pathway
|
Function
|
Known
|
Explain
|
0.06690
|
|
47
|
Pseudopapilledema
|
Disease
|
Inferred
|
Explain
|
0.06573
|
|
48
|
response to zinc ion
|
Function
|
Known
|
Explain
|
0.06452
|
|
49
|
Polydactyly
|
Other
|
Known
|
Explain
|
0.06230
|
|
50
|
Developmental Disabilities
|
Disease
|
Known
|
Explain
|
0.05713
|
|
51
|
1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate
|
Compound
|
Known
|
Explain
|
0.04896
|
|
52
|
miRBase:hsa-mir-26a
|
MicroRNA
|
Known
|
Explain
|
0.04761
|
|
53
|
MAST3 gene
|
Gene
|
Known
|
Explain
|
0.04483
|
|
54
|
protein tyrosine/serine/threonine phosphatase activity
|
Function
|
Known
|
Explain
|
0.04400
|
|
55
|
miRBase:hsa-mir-214
|
MicroRNA
|
Known
|
Explain
|
0.04378
|
|
56
|
MVP gene
|
Gene
|
Known
|
Explain
|
0.04351
|
|
57
|
CHGB gene
|
Gene
|
Known
|
Explain
|
0.04310
|
|
58
|
negative regulation of protein amino acid phosphorylation
|
Function
|
Known
|
Explain
|
0.04241
|
|
59
|
MAGI2 gene
|
Gene
|
Known
|
Explain
|
0.04099
|
|
60
|
Endometrial Neoplasms
|
Disease
|
Known
|
Explain
|
0.04035
|
|
61
|
MAST1 gene
|
Gene
|
Known
|
Explain
|
0.03918
|
|
62
|
FRK gene
|
Gene
|
Known
|
Explain
|
0.03905
|
|
63
|
negative regulation of epithelial cell proliferation
|
Function
|
Known
|
Explain
|
0.03784
|
|
64
|
MAGI3 gene
|
Gene
|
Known
|
Explain
|
0.03734
|
|
65
|
HBA1 gene
|
Gene
|
Known
|
Explain
|
0.03714
|
|
66
|
Memory
|
Function
|
Known
|
Explain
|
0.03615
|
|
67
|
Multiple congenital anomalies
|
Other
|
Known
|
Explain
|
0.03482
|
|
68
|
Head and Neck Neoplasms
|
Disease
|
Known
|
Explain
|
0.03465
|
|
69
|
SQUAMOUS CELL CARCINOMA, HEAD AND NECK
|
Disease
|
Known
|
Explain
|
0.03457
|
|
70
|
Protein-tyrosine phosphatase, active site
|
Domain
|
Known
|
Explain
|
0.03370
|
|
71
|
Macrocephaly
|
Other
|
Inferred
|
Explain
|
0.03327
|
|
72
|
Profound Mental Retardation
|
Disease
|
Known
|
Explain
|
0.03322
|
|
73
|
negative regulation of cell migration
|
Function
|
Known
|
Explain
|
0.03254
|
|
74
|
MAST2 gene
|
Gene
|
Known
|
Explain
|
0.03217
|
|
75
|
protein serine/threonine phosphatase activity
|
Function
|
Known
|
Explain
|
0.03151
|
|
76
|
protein stabilization
|
Function
|
Known
|
Explain
|
0.03145
|
|
77
|
positive regulation of transcription factor activity
|
Function
|
Known
|
Explain
|
0.03084
|
|
78
|
regulation of cyclin-dependent protein kinase activity
|
Function
|
Known
|
Explain
|
0.02995
|
|
79
|
UTP14A gene
|
Gene
|
Known
|
Explain
|
0.02825
|
|
80
|
PDZ domain binding
|
Function
|
Known
|
Explain
|
0.02816
|
|
81
|
Sirolimus
|
Compound
|
Known
|
Explain
|
0.02605
|
|
82
|
Inositol Phosphate Metabolism Pathway
|
Function
|
Known
|
Explain
|
0.02402
|
|
83
|
Meningioma, benign, no ICD-O subtype
|
Disease
|
Inferred
|
Explain
|
0.02374
|
|
84
|
Wnt receptor signaling pathway through beta-catenin
|
Function
|
Known
|
Explain
|
0.02374
|
|
85
|
leukemia
|
Disease
|
Known
|
Explain
|
0.02348
|
|
86
|
Refractive Errors
|
Disease
|
Inferred
|
Explain
|
0.02320
|
|
87
|
SLC9A3R2 gene
|
Gene
|
Known
|
Explain
|
0.02295
|
|
88
|
Glioma
|
Disease
|
Known
|
Explain
|
0.02244
|
|
89
|
Endometrial cancer - Homo sapiens (human)
|
Pathway
|
Known
|
Explain
|
0.02161
|
|
90
|
response to glucose stimulus
|
Function
|
Known
|
Explain
|
0.02159
|
|
91
|
ANG gene
|
Gene
|
Known
|
Explain
|
0.02153
|
|
92
|
inositol or phosphatidylinositol phosphatase activity
|
Function
|
Inferred
|
Explain
|
0.02143
|
|
93
|
protein tyrosine phosphatase activity
|
Function
|
Known
|
Explain
|
0.02079
|
|
94
|
miRBase:hsa-mir-21
|
MicroRNA
|
Known
|
Explain
|
0.02075
|
|
95
|
STK11 gene
|
Gene
|
Known
|
Explain
|
0.01933
|
|
96
|
response to estradiol stimulus
|
Function
|
Known
|
Explain
|
0.01929
|
|
97
|
Dysplastic Nevus Syndrome
|
Disease
|
Inferred
|
Explain
|
0.01907
|
|
98
|
C2 calcium/lipid-binding region, CaLB
|
Domain
|
Known
|
Explain
|
0.01895
|
|
99
|
Glioma - Homo sapiens (human)
|
Pathway
|
Known
|
Explain
|
0.01886
|
|
100
|
SLC9A3R1 gene
|
Gene
|
Known
|
Explain
|
0.01866
|